Abstract:Background: Aneurysm subarachnoid hemorrhage (aSAH) is a life-threatened disease. Stress responded hyperglycemia following aSAH was one of most important predictors that was associated with poor outcomes and higher mortality of patients critically suffered from aSAH. Thus, optimal glucose management strategy could improve outcomes of aSAH patients in Neurocritical Care Unit (NCU). However, it’s still lacks of evidence on glucose level which is beneficial for severe aSAH patients. Recently, glucose variability (GV) was not only used to predict clinical outcomes and mortality, but also used as a more appropriated clinical target than blood glucose range only to manage glucose level. Our study aimed to find a relatively suitable glucose control for aSAH patients in NCU. Method: 332 patients were recruited from a retrospectively collected database of all patients with aneurysm SAH (aSAH) who were admitted to Tiantan Hospital in Beijing, China between January 2015 and December 2017. We collected continuous 14-day blood glucose and calculated glucose variability. Continuous 14-day blood glucose level were divided into four groups: stable, unstable, well-controlled, bad-controlled. Other predictor variables also included admission Hunt and Hess grade, age, gender, cardiovascular risk factors, and surgical treatment. In-patient mortality was the main outcome measure. Results: Univariate survival analysis showed that the stable and well-controlled groups have higher percentage of cumulative survival than the rest two groups. Then, Multivariate COX regression analysis showed that Hunt Hess scale (HR 2.666, 95% CI, 1.438-4.944), receiving Surgery (HR 0.073, 95% CI, 0.025-0.219), having hydrocephalus (HR 3.844, 95% CI, 1.038-14.228), bleeding in cisterna ambiens (HR 8.288, 95% CI, 2.270-30.259),bad-controlled glucose (HR 5.788, 95% CI, 1.441-23.237) and unstable glucose (HR 15.403, 95% CI, 2.666-88.987). Conclusions: GV is helpful to predict aSAH mortality, either long-term or short-term. Glucose fluctuated between 7 and 10 mmol/L is associated with better 14-day clinical outcomes for critically ill aSAH patients in NCU. Funding Statement: None. Declaration of Interests: The authors declare that they have no conflict of interest. Ethics Approval Statement: This retrospective study was approved by the Ethics Committee at the Tiantan Hospital in Beijing, in accordance with the Declaration of Helsinki; patient informed consent was not required because of the anonymous nature of the data.

Continuous Glucose Monitoring During Early Phase of Acute Ischemic Stroke in Patients Without Diabetes Mellitus History

Correlation of Stress Hyperglycemia after Ischemic Stroke with Early Vascular Cognitive Impairment

A Continuous Glycemic Observation During Early Phase of Acute Myocardial Infarction in Patients Without Known Diabetes Mellitus

Glucose Fluctuations in Acute Ischemic Stroke

Performance of Continuous Glucose Monitoring System Among Patients With Acute Ischaemic Stroke Treated With Mechanical Thrombectomy

Effects of Glucose Fluctuation Targeted Intervention on the Prognosis of Patients with Type 2 Diabetes Following the First Episode of Cerebral Infarction

Hyperglycemic Patterns in Acute Stroke Patients

The study of intensive insulin versus standard insulin for prognosis in patients with acute cerebral infarction and post stroke hyperglycemia

Association Between the First Poststroke Random Blood Glucose Levels and the Severity and Prognosis of Stroke

Association between glucose parameters and outcome measures in acute ischemic stroke with intravenous thrombolytic treatment

The acute-to-chronic glycemic ratio correlates with the severity of illness at admission in patients with diabetes experiencing acute ischemic stroke

Increased Two-Hour Post-Load Plasma Glucose Fluctuation Corresponds with Worse Clinical Prognoses among Acute Ischemic Stroke Patients without a History of Diabetes Mellitus

Role of hyperglycemia in acute and recovery phases of the patients with arteriosclerotic cerebral infarction

Author Response for "performance of Continuous Glucose Monitoring System among Patients with Acute Ischaemic Stroke Treated with Mechanical Thrombectomy"

Inordinate Glucose Variation Poststroke is Associated with Poor Neurological Improvement in Patients Without History of Diabetes

Abnormal Glucose Regulation, Hypoglycemic Treatment During Hospitalization and Prognosis of Acute Ischemic Stroke

14-Day Continuous Glucose Level and Mortality in Aneurysm SAH: A Retrospective Study in Neurocritical Care Unit

Abstract WP3: Serum Glucose Fluctuations is an Independent Predictor of Adverse Outcomes in Patients With Acute Ischemic Stroke Undergoing Endovascular Treatment

Association of Admission Glucose and Outcomes After Endovascular Treatment for Acute Stroke: Data From the ANGEL-ACT Registry

Abstract WMP3: Hyperglycemic Control In Acute Ischemic Stroke Patients Undergoing Endovascular Treatment: Post-hoc Analysis Of Stroke Hyperglycemia Insulin Network Effort Trial

Hyperglycemic control in acute ischemic stroke patients undergoing endovascular treatment: post hoc analysis of the Stroke Hyperglycemia Insulin Network Effort trial